Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
(Weinh) 11, e2406473
This trial provides the primary efficacy and safety data supporting the regulatory submission for obesity
Semaglutide is a medicine generally used to manage type 2 diabetes and support weight loss
A comparative analysis was conducted using disproportionality analysis, reporting odds ratio (ROR), and stratified analysis methods to assess and compare the signals of adverse events (AE) and the time to onset of adverse reactions associated with different routes of administration of semaglutide from 2017 to 2023
Rajendiran, A
US$ 23.44
US$ 27.59
US$ 22.63
US$ 22.39
US$ 20.29
US$ 29.41
